edoc

Successful memory response following an up to 11 years delayed booster dose with a virosome-formulated hepatitis a vaccine (Epaxal(R))

Hatz, C. and van der Ploeg, R. and Beck, B. R. and Frosner, G. and Hunt, M. and Herzog, C.. (2011) Successful memory response following an up to 11 years delayed booster dose with a virosome-formulated hepatitis a vaccine (Epaxal(R)). Clinical and vaccine immunology, Vol. 18, H. 5. pp. 885-887.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6002357

Downloads: Statistics Overview

Abstract

Boosting adult travellers with the virosome-formulated, aluminum-free hepatitis A vaccine Epaxal(R) up to 128 months after a single primary dose confers full protection against hepatitis A, even in travellers aged 50 years and above. Delaying the booster dose did not influence the immune memory response to Epaxal(R).
Faculties and Departments:03 Faculty of Medicine > Departement Public Health > Sozial- und Präventivmedizin > Medicines Development (Paris)
09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH) > Department of Medicine (MED) > Medicines Development (Paris)
09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH) > Department of Medical Parasitology and Infection Biology (MPI) > Clinical Immunology (Daubenberger)
UniBasel Contributors:Hatz, Christoph
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:American Society for Microbiology
ISSN:1556-6811
Note:Publication type according to Uni Basel Research Database: Journal article
Related URLs:
Identification Number:
Last Modified:16 Feb 2018 13:10
Deposited On:08 Nov 2012 16:09

Repository Staff Only: item control page